Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.437
+0.017 (1.16%)
Jul 28, 2026, 1:07 PM EDT - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10.34 million as of July 28, 2026. Its market cap has decreased by -50.48% in one year.
Market Cap
10.34M
Enterprise Value
2.18M
1-Year Change
-50.48%
Ranking
Category
Stock Price
$1.44
ChartMarket Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.34M, a decrease of -98.36%. That is a compound annual growth rate of -53.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 10.34M | 1.85% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 11.25M |
| Exicure | 11.22M |
| Lunai Bioworks | 10.56M |
| BioVie | 10.33M |
| Theriva Biologics | 10.23M |
| BioCardia | 9.67M |
| Curis | 9.53M |
| Aspire Biopharma Holdings | 9.40M |